SilvaAArslanianMD

Endocrinology • Pittsburgh, PA

Diabetes, Pediatric Endocrinology

Professor of Pediatrics, University Pittsburgh

Join to view full profile

Dr. Arslanian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Arslanian's full profile

Already have an account?

Office
3705 5th Ave
Pittsburgh, PA 15213
Phone+1 412-692-5170

Fax+1 412-692-8531

Education & Training

UPMC Medical EducationFellowship, Pediatric Endocrinology, 1980 - 1984
American University of Beirut Faculty of MedicineClass of 1978

Certifications & Licensure

PA State Medical License 1982 - 2024
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Endocrinology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2004-2014
Pittsburgh Magazine Castle Connolly, 2005, 2008-2011

Clinical Trials

Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study Start of enrollment: 2005 Mar 01
Completed
Phase 4
TODAY Genetics Study Start of enrollment: 2008 Aug 01
Completed
Childhood Metabolic Markers of Adult Morbidity in Blacks Start of enrollment: 2004 Jul 01
Completed
TODAY2 Phase 1 Immediate Post-Intervention Observational Follow-up Study Start of enrollment: 2011 Mar 01
Completed
RISE Pediatric Medication Study Start of enrollment: 2013 Jun 16
Completed
Phase 3
A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes Start of enrollment: 2016 Dec 29
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

Dulaglutide and Glomerular Hyperfiltration, Proteinuria, and Albuminuria in Youth With Type 2 Diabetes: Post Hoc Analysis of the AWARD-PEDS Study.
Petter Bjornstad, Silva A Arslanian, Tamara S Hannon, Philip S Zeitler, Jennie L Francis
Diabetes Care. 2024-09-01
A Mathematical Model-Derived Disposition Index Without Insulin Validated in Youth with Obesity.
Joon Ha, Joon Young Kim, Max Springer, Aaryan Chhabra, Stephanie T Chung
The Journal of Clinical Endocrinology and Metabolism. 2024-08-22
1 citations
Semaglutide for management of obesity in adolescents: efficacy, safety, and considerations for clinical practice.
Megan O Bensignor, Silva Arslanian, Mary Ellen Vajravelu
Current Opinion in Pediatrics. 2024-08-01

Journal Articles

Evaluation and Management of Youth-Onset Type 2 Diabetes: A Position Statement by the American Diabetes Association
Silva Arslanian, Fida Bacha, Neil H White, Philip Zeitler, Diabetes Care

Lectures

Adipose Tissue Insulin Resistance in Youth on the Spectrum from Normal Weight to Obese and from Normal Glucose Tolerance to Impaired Glucose Tolerance to Type 2 Diabetes
European Association for the Study of Diabetes, 47th Annual Meeting, Lisbon, Portugal
Journal of Pediatrics
47th Annual Meeting, Lisbon, Portugal
Journal of Pediatrics
Pittsburgh, PA - 6/13/2014
Adipose Tissue Insulin Resistance in Youth on the Spectrum from Normal Weight to Obese and from Normal Glucose Tolerance to Impaired Glucose Tolerance to Type 2 Diabetes
American Diabetes Association, San Francisco, California - 2/17/2012
Join now to see all

Press Mentions

FDA-Approved Weight Loss Drug for Adults Successful in ChildrenNovember 16th, 2022
Weight-Loss Drug, Approved for Adults, Shows Promise in KidsNovember 11th, 2022
Semaglutide Reduces BMI More Than Lifestyle Changes in Teens with ObesityNovember 3rd, 2022
Join now to see all

Grant Support

Insulin Resistance In ChildhoodEunice Kennedy Shriver National Institute Of Child Health &Human Development2009–2011
Childhood Metabolic Markers Of Adult Morbidity In BlacksEunice Kennedy Shriver National Institute Of Child Health &Human Development2008–2009
Insulin Resistance In ChildhoodEunice Kennedy Shriver National Institute Of Child Health &Human Development2000–2008
Childhood Metabolic Markers Of Adult Morbidity In BlacksEunice Kennedy Shriver National Institute Of Child Health &Human Development1997–2008
Research And Academic Training In Pediatric DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2007
Type 2 Diabetes In YOUTH: Beta Cell PreservationNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2007
Studies To Treat Or Prevent Pediatric Type 2 Diabetes (Stopp-T2d)National Center For Research Resources2005
Academic Career Development In Pediatric Diabetes(K12)National Institute Of Diabetes And Digestive And Kidney Diseases2003–2005
Childhood Metabolic Markers Of Adult Morbidity In BlacksNational Center For Research Resources1996–2005
Higher IGF1 In Black Vs. White Children: Does Ghrelin Play A Role?National Center For Research Resources2004
Physical &Metabolic Characteristics Of Hair An &Pcos In ChildrenNational Center For Research Resources1999–2002
Anabolic Effects Of Dihydrotestosterone-- Role Of GHNational Center For Research Resources1999–2002
Energy Metabolism And Insulin Resistance During PubertyNational Center For Research Resources1993–1999
Pathogenesis Of Glucose Intolerance In Cystic FibrosisNational Center For Research Resources1994–1996
Energy Metabolism And Insulin Resistance During PubertyEunice Kennedy Shriver National Institute Of Child Health &Human Development1991–1995
Pathogenesis Of Glucose Intolerance In Cystic Fibrosis (CF) PatientsNational Center For Research Resources1990–1993
Grf-44 Treatment Of Growth Hormone Deficient ChildrenNational Center For Research Resources1990